Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Analysis of methylation pattern in multiple myeloma.

Jesús San-Miguel1, Ramón García-Sanz, Ricardo López-Pérez

  • 1Servicio de Hematología, Hospital Universitario de Salamanca, Centro de Investigación del Cáncer, Universidad de Salamanca, Salamanca, Spain. sanmigiz@usal.es

Acta Haematologica
|September 17, 2005
PubMed
Summary

DNA methylation, a key epigenetic process, silences gene expression. P16 gene methylation was observed in multiple myeloma, suggesting its role in cell cycle regulation and potential therapeutic targets.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Transcriptomic landscape of peripheral T cells following CAR-T cell therapy in diffuse large B cell lymphoma.

Cancer immunology, immunotherapy : CII·2026
Same author

Stromal and endothelial transcriptional changes during progression from MGUS to myeloma and after treatment response.

Nature communications·2026
Same author

A plain language summary describing how talquetamab affects the way people with multiple myeloma feel and function in the MonumenTAL-1 study.

Future oncology (London, England)·2026
Same author

Validation of ELN 2024 genetic classification in patients with AML treated with HMA-based regimens: PETHEMA registry study.

Blood neoplasia·2026
Same author

Development and validation of a novel prognostic index for mantle cell lymphoma integrating TP53 mutations (MIPI53).

British journal of haematology·2026
Same author

Plain language summary of a study on 30-minute intravenous infusion of isatuximab in people with newly diagnosed multiple myeloma.

Future oncology (London, England)·2026

Area of Science:

  • Epigenetics and Molecular Oncology
  • Cancer Biology

Background:

  • DNA methylation is a critical epigenetic mechanism involved in gene silencing and cancer development.
  • The p16 gene, a tumor suppressor, regulates the cell cycle and its methylation is implicated in various solid tumors.

Purpose of the Study:

  • To investigate the methylation status of the p16 gene in patients with multiple myeloma and primary plasma cell leukaemias.
  • To explore the role of p16 gene methylation in cell cycle regulation within the context of multiple myeloma.

Main Methods:

  • Analysis of p16 gene methylation status in 159 patients.
  • Comparison of methylation frequencies between multiple myeloma and primary plasma cell leukaemia cohorts.

Main Results:

Related Experiment Videos

  • P16 gene methylation was detected in 42% of multiple myeloma patients (41/98).
  • A higher frequency of p16 gene methylation (80%) was observed in primary plasma cell leukaemias (4/5).
  • Findings support the significance of p16 methylation in multiple myeloma cell cycle regulation.

    • Conclusions:

    • P16 gene methylation plays a role in the progression of multiple myeloma.
    • Epigenetic mechanisms like DNA methylation offer potential therapeutic strategies, including demethylating agents and histone deacetylase inhibitors.
    • Further research into epigenetic therapies is crucial for improving outcomes in multiple myeloma, an incurable disease.